mTOR/JAK inhibitor combination therapy

Assignee

• Novartis Pharma Ag
• Incyte

Inventors

• Alessandro M. Vannucchi (3 patents)
• Costanza Bogani (2 patents)
• Paola Guglielmelli (1 patents)

View full patent text on Google Patents →